10Y UST4.74%+1.07%30Y MTG6.65%-0.30%SOFR3.65%+0.55%VNQ$99.10+0.61%XLRE$45.33+0.55%FED FUNDS3.63%
Real Estate Trail
Institutional Press Wire
REBusiness Online

Genentech to Invest $750M in Manufacturing Facility in Hillsboro, Oregon

Via REBusiness Online · August 24, 2026
Compiled by Real Estate Trail Editorial · August 24, 2026

Why this matters

Commercial real estate continues to digest a multi-year reset in cost of capital. Transaction velocity is below the 2019-2021 trend but improving, cap rates have stabilized across most stabilized property types, and the bid-ask gap has narrowed materially in the past two quarters. Sponsors with permanent capital and operating platforms have an advantage in the current execution environment. The next twelve months will continue to reward underwriting discipline and operational sophistication over balance-sheet aggression.

Editorial analysis · Real Estate Trail Editorial

Excerpt from REBusiness Online:
HILLSBORO, ORE. — Genentech, a member of the Roche Group, plans to invest $750 million in a new device fill-finish manufacturing facility at its 75-acre campus in Hillsboro. The development will bring new end-to-end d…
Read the full article at REBusiness Online

External link. Real Estate Trail does not republish source content.

More from the wire